| Year |
Title |
Altmetric |
| 2021
|
A rise in social media utilization by U.S. neurology residency programs in the era of COVID-19.
Clinical Neurology and Neurosurgery.
207.
2021
|
|
| 2021
|
Association of Initial β-Amyloid Levels with Subsequent Flortaucipir Positron Emission Tomography Changes in Persons without Cognitive Impairment.
JAMA Neurology.
78:217-228.
2021
|
|
| 2020
|
A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease.
Scientific Reports.
10.
2020
|
|
| 2020
|
Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (Scientific Reports, (2019), 9, 1, (13845), 10.1038/s41598-019-49970-9).
Scientific Reports.
10.
2020
|
|
| 2020
|
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology.
Scientific Reports.
10.
2020
|
|
| 2020
|
Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients with Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.
JAMA Neurology.
77:215-224.
2020
|
|
| 2019
|
A blood-based signature of cerebrospinal fluid Aβ 1–42 status.
Scientific Reports.
9.
2019
|
|
| 2019
|
Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways.
Scientific Reports.
9.
2019
|
|
| 2019
|
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification.
Scientific Reports.
9.
2019
|
|
| 2019
|
Predicting Alzheimer’s disease progression using multi-modal deep learning approach.
Scientific Reports.
9.
2019
|
|
| 2019
|
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.
Scientific Reports.
9.
2019
|
|
| 2019
|
Genome sequencing for early-onset dementia: high diagnostic yield and frequent observation of multiple contributory alleles
2019
|
|
| 2019
|
Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia.
Molecular Neurobiology.
56:4916-4924.
2019
|
|
| 2019
|
Genome sequencing for early-onset or atypical dementia: High diagnostic yield and frequent observation of multiple contributory alleles.
Cold Spring Harbor molecular case studies.
5.
2019
|
|
| 2018
|
Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states.
Scientific Reports.
8.
2018
|
|
| 2018
|
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images.
Scientific Reports.
8.
2018
|
|
| 2018
|
18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery..
Anesthesiology.
128:728-744.
2018
|
|
| 2017
|
Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features.
Scientific Reports.
7.
2017
|
|
| 2017
|
Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty.
Scientific Reports.
7.
2017
|
|
| 2017
|
Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease.
JAMA Neurology.
74:557-566.
2017
|
|
| 2017
|
Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease.
Scientific Reports.
7.
2017
|
|
| 2017
|
Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease.
Neurobiology of Aging.
49:216.e7.
2017
|
|
| 2016
|
Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults.
JAMA Neurology.
73:721-732.
2016
|
|
| 2014
|
The future of neuroscience clinical trials-reply..
JAMA Neurology.
71:652-653.
2014
|
|
| 2014
|
In reply.
JAMA Neurology.
71:652-653.
2014
|
|
| 2013
|
Normal cognitive aging.
Clinics in Geriatric Medicine.
29:737-752.
2013
|
|
| 2013
|
Network for excellence in neuroscience clinical trials NeuroNEXT.
JAMA Neurology.
70:1227-1228.
2013
|
|
